Jani Yogini Hariprasad, Barber Nick, Wong Ian Chi Kei
Centre for Paediatric Pharmacy Research, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Qual Saf Health Care. 2010 Aug;19(4):337-40. doi: 10.1136/qshc.2009.033068.
To compare the incidence and severity rating of dose prescribing errors before and after the implementation of a commercially available electronic prescribing system at a tertiary care children's hospital.
Dose errors were identified using prescription review to detect errors. Severity rating was determined by five judges using a validated, reliable scoring tool. The mean score for each error was used as an index of severity.
Dose prescribing errors occurred in 88 of the 3939 (2.2%) items prescribed for outpatients and inpatients, and on discharge prescriptions prior to the implementation of electronic prescribing (EP). After EP, there were 57 dose errors in 4784 (1.2%) items prescribed (1% absolute reduction (p<0.001 chi(2) test; 95% CI of difference in proportions -1.6% to -0.5%)). A decrease in the severity rating of dose errors was also seen: dose errors with potentially minor outcomes 35/3939 (0.89%) pre vs 21/4784 (0.44%) post (95% CI of difference in proportions -0.8% to -0.11%, p=0.009 chi(2) test); moderate outcome 46/3939 (1.17%) pre vs 33/4784 (0.69%) post (95% CI of difference in proportions -0.91% to -0.08, p=0.019, chi(2) test); severe outcome: 7/3939 (0.18%) pre vs 3/4784 (0.06%) post (95% CI of difference in proportions -0.31% to +0.04, p=0.11, chi(2) test).
Electronic prescribing appears to reduce rates of dosing errors in paediatrics, but larger studies are required to assess the effect on the severity of these errors and in different settings.
比较在一家三级护理儿童医院实施商用电子处方系统前后剂量处方错误的发生率和严重程度评级。
通过处方审查来识别剂量错误以检测错误。由五名评判员使用经过验证的可靠评分工具确定严重程度评级。每个错误的平均分数用作严重程度指标。
在实施电子处方(EP)之前,门诊和住院患者以及出院处方所开具的3939项中有88项(2.2%)出现剂量处方错误。实施EP后,在开具的4784项中有57项剂量错误(1.2%)(绝对降低1%(p<0.001,卡方检验;比例差异的95%置信区间为-1.6%至-0.5%))。剂量错误的严重程度评级也有所降低:潜在轻微后果的剂量错误在实施前为35/3939(0.89%),实施后为21/4784(0.44%)(比例差异的95%置信区间为-0.8%至-0.11%,p=0.009,卡方检验);中等后果的剂量错误在实施前为46/3939(1.17%),实施后为33/4784(0.69%)(比例差异的95%置信区间为-0.91%至-0.08,p=0.019,卡方检验);严重后果的剂量错误在实施前为7/3939(0.18%),实施后为3/4784(0.06%)(比例差异的95%置信区间为-0.31%至+0.04,p=0.11,卡方检验)。
电子处方似乎能降低儿科用药错误率,但需要更大规模的研究来评估其对这些错误严重程度的影响以及在不同环境中的影响。